Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis

Published:2020-08 Issue:2 Volume:81 Page:276-281
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Pirola Carlos J.,Sookoian Silvia

Funder

Consejo Nacional de Investigaciones Científicas y Técnicas

Fondo para la Investigación Científica y Tecnológica

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference23 articles.

1. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor;Hoffmann;Cell,2020

2. Age but not sex may explain the negative effect of arterial hyptertension and diabetes on COVID-19 prognosis;Pirola;J Infect,2020

3. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area;Richardson;JAMA,2020

4. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

5. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers;Danser;Hypertension,2020

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overreactive macrophages in SARS-CoV-2 infection: The effects of ACEI;International Immunopharmacology;2023-11

2. New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System;Journal of the Renin-Angiotensin-Aldosterone System;2023-07-12

3. Outcomes of COVID‐19 hospitalizations in patients with sickle cell disease: A nationwide analysis;European Journal of Haematology;2023-06-08

4. Drugs in primary care that may alter COVID-19 risk and severity;JAAPA;2023-05

5. RAAS-Hemmung und darüber hinaus – Herz-Kreislauf-Medikation bei Patienten mit einem Risiko für oder Erkrankung durch COVID-19;Herz;2023-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3